YKL-40 as a novel diagnostic biomarker in Toxoplasmosis

被引:5
|
作者
Shahad, Farah Abd AL-Zahra [1 ]
Mohammed, Ahmed A. [1 ]
Jasim, Ghaith Ali [2 ]
机构
[1] Univ Mustansiriyah, Branch Clin Lab Sci, Coll Pharm, Baghdad, Iraq
[2] Univ Mustansiriyah, Branch Pharmacol & Toxicol, Coll Pharm, Baghdad, Iraq
关键词
biomarkers; diagnosis; Toxoplasma gondii; Toxoplasmosis; YKL-40; PREGNANT-WOMEN; GONDII; IMMUNITY; EPIDEMIOLOGY; PATHOGENESIS; IGM;
D O I
10.47750/jptcp.2022.932
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Toxoplasmosis is one of the most globally prevalent zoonotic infection caused by an obligate, intracellular parasite called Toxoplasma gondii. Toxoplasmosis actively triggers an acute immune response and inflammatory reactions, which causes serious pathological changes in various tissues in the human body, and more evidently localizes in different nervous tissues of various body organs. The YKL-40 is a glycoprotein secreted by numerous cell types in different patterns associated with various pathological processes such as inflammatory reactions, tissue remodeling, and fibrosis, and is a disease-specific biomarker of neuroinflammation. Therefore, this study aimed to determine whether the YKL-40 is markedly increased in toxoplasmosis or not and whether its level is different between the acute and chronic phases of the infection to determine if it can be used as a clinically useful biomarker in the diagnosis, and determination of disease severity and follow-up of toxoplasmosis. Accordingly, a total of 80 serum samples were collected from previously diagnosed female patients of different ages with toxoplasmosis. In addition, serum samples of 10 healthy females were used as the control. Patients were first divided into two groups (30 patients with acute infection, and 50 patients with chronic infection) depending on the results of detection of specific anti-Toxoplasma IgM and IgG by enzyme linked immunosorbent assay (ELISA). The level of YKL-40 was then measured in the patients' serum by ELISA. The statistical analysis of data clearly disclosed very highly significant differences (P < 0.001) between the level of YKL-40 in the acute infection group and healthy controls, chronic infection group and healthy controls, and between the groups with acute and chronic infections. These findings led to conclude that YKL-40 classify as a unique and sophisticated biomarker in the diagnosis of toxoplasmosis where it can vitally be used to detect the stage of the disease, whether acute or chronic, besides its ability to detect the infection.
引用
收藏
页码:E61 / E70
页数:10
相关论文
共 50 条
  • [1] A novel biomarker in acute cholecystitis: YKL-40
    Celikturk, Eray
    Salt, Omer
    Sayhan, Mustafa Burak
    Dibirdik, Ilker
    ASIAN JOURNAL OF SURGERY, 2023, 46 (04) : 1564 - 1570
  • [2] YKL-40 As biomarker in severe asthma
    Castro, E. M. C.
    Lockett, G. A.
    Lau, L. C.
    Barber, C.
    Scott, E.
    Brown, T.
    Chauhan, A.
    Holloway, J. W.
    Howarth, P. H.
    ALLERGY, 2019, 74 : 106 - 106
  • [3] YKL-40 as new cardiac biomarker
    Wiwanitkit, Viroj
    ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY, 2014, 14 (01): : 98 - 99
  • [4] Ykl-40 as a biomarker of severe asthma
    Castro, M. C. E.
    Locket, G.
    Lau, L.
    Howarth, P.
    Holloway, J.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2016, 46 (12): : 1625 - 1626
  • [5] YKL-40: a Potential Biomarker for Osteoarthritis
    Huang, K.
    Wu, L. D.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2009, 37 (01) : 18 - 24
  • [6] YKL-40 as new cardiac biomarker Reply
    Kocaman, Sinan Altan
    Cetin, Mustafa
    Durakoglugil, Murtaza Emre
    Erdogan, Turan
    ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY, 2014, 14 (01): : 99 - 99
  • [7] YKL-40: a potential biomarker for psoriatic arthritis?
    Jensen, P.
    Wiell, C.
    Milting, K.
    Poggenborg, R.
    Ostergaard, M.
    Johansen, J.
    Skov, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (06) : E15 - E16
  • [8] YKL-40: a new biomarker in cardiovascular disease?
    Mathiasen, Anders Bruun
    Henningsen, Kristoffer Mads Aaris
    Harutyunyan, Marina Jurjevna
    Mygind, Naja Dam
    Kastrup, Jens
    BIOMARKERS IN MEDICINE, 2010, 4 (04) : 591 - 600
  • [9] YKL-40 a Potential Biomarker for Colorectal Cancer
    Swayze, Hannah K.
    Chapman, Christopher N.
    Cao, Jackie
    Shao, Rong
    Arenas, Richard B.
    Bentley, Brooke
    GASTROENTEROLOGY, 2009, 136 (05) : A937 - A937
  • [10] The serum YKL-40 is a useful biomarker for asthma
    Tong, Xiang
    Liu, Sitong
    Ma, Yao
    Wang, Dongguang
    Fan, Hong
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50